NEUROPRO THERAPEUTICS
Live / Registered — Registered (as of 02 Jun 2026)
What this means for you
Registered since 02 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jun 2032: the §8 declaration of use).
Record
- Serial number
- 98791998
- Registration number
- 8279340
- Mark type
- Design + words
- Filed
- 09 Oct 2024
- Published for opposition
- 14 Apr 2026
- Registered
- 02 Jun 2026
- Next maintenance filing
- §8 declaration of use, due by 02 Jun 2032 (grace period to 02 Dec 2032)
- Attorney of record
- FRANCIS P. CISLAK
Goods and services
- Class 042 — Scientific and technological services: pharmaceutical research services in the field of neurological diseases and disorders; pharmaceutical products development in the field of neurological diseases and disorders; pharmaceutical product evaluation in the field of neurological diseases and disorders
Owner
- NeuroPro Therapeutics, Inc., Yachats, OR, US
- NeuroPro Therapeutics, Inc., Yachats, OR, US
- NeuroPro Therapeutics, Inc., Yachats, OR, US
Board proceedings on this mark
- Ex Parte Appeal No. 98791998 — NeuroPro Therapeutics, Inc., filed 20 Feb 2026 (Terminated)
Prosecution history
- 02 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 14 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Apr 2026 — PUBLISHED FOR OPPOSITION
- 08 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Mar 2026 — EXPARTE APPEAL TERMINATED
- 17 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Feb 2026 — EX PARTE APPEAL-INSTITUTED
- 20 Feb 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 20 Feb 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 12 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Feb 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 08 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 08 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED